MELBOURNE, Australia--(BUSINESS WIRE)--Illumina, Inc., the global leader in DNA sequencing and array-based technologies and Next Generation Genomic Co., Ltd. (NGG Thailand), the Association of ...
Illumina received an emergency authorization from the FDA for its COVID-19 test designed to sequence the full genome of the novel coronavirus. Using the company’s high-throughput NovaSeq 6000 hardware ...
SAN DIEGO, June 7, 2022 /PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today shared key customer-focused announcements and presentations ...
SAN DIEGO--(BUSINESS WIRE)--Illumina, Inc. (NASDAQ:ILMN) today announced it has expanded the world’s most comprehensive next-generation sequencing (NGS) portfolio with the launch of the HiSeq X Five ...
San Diego’s Illumina has won regulatory approval for the first COVID-19 test based on next- generation gene sequencing, which could help track mutations of the virus while delivering high-volume ...
International Day of World’s Indigenous Peoples is celebrated each year on August 9. On this day, people from around the world are encouraged to spread the United Nation’s message on the protection ...
Federal regulators are hoping to thwart a large diagnostics company’s efforts to acquire a smaller firm in the same space, saying that it is a move to reduce competition in the market. Shares of ...
San Diego’s Illumina has won regulatory approval for the first COVID-19 test based on next- generation gene sequencing, which could help track mutations of the virus while delivering high-volume ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback